VU rejoins ILCA as a core partner
June 28, 2021The Chemistry and Pharmaceutical sciences group at Vrije Universiteit Amsterdam (VU) has recently rejoined Innovation Lab Chemistry (ILCA), which provides innovation support to chemical companies, supported by various organisations in the region. With this participation, the VU hopes to contribute new knowledge and expertise in addition to the existing universities that are
already part of the Innovation Lab.
At ILCA it is seen as good news: “We are very pleased that VU adds their Pharmaceutical chemistry knowledge to the portfolio of expertise of ILCA. This means that companies and organizations in the MRA can benefit from a broader range of services to support their innovations and operational challenges”, says Willem Fokkema, director at ILCA.
The participation of VU will be coordinated by IXA-VU. “We make sure that questions from companies arrive on the right place” adds Ties van Rappard, business developer at VU. “We have extensive pharmaceutical expertise and (analytical) infrastructure in the labs of Prof Tom Grossmann useful for Lifesciences startup companies but also for mature companies in need for specific instruments. Regardless the question; analysis or synthesis. We find solutions”.
More news
Contribute to Amsterdam’s Future: test your innovation at SAIL and the Amsterdam Marathon
Are you looking for a testing ground for your innovation? SAIL and the Amsterdam Marathon present an excellent opportunity to test your ideas. These major events attract millions of visitors and come with sustainability, accessibility, and logistical challenges that need fresh solutions. The In Residence Events program allows you to test your innovation during these […]
News
Tackling learning difficulties in Academic Workplace
The Academic Workplace Rudolf Berlin Center (AW RBC) aims to make a meaningful contribution by supporting young people with learning disabilities through enhanced education and care.
News
VU researchers develop research equipment to identify contaminants in water
Water, comprising over 70% of our planet, is the source of all life. The presence of emerging contaminants in our water, including pharmaceuticals, pose serious health and environmental risks, such as DNA damage, reproductive issues, and cancer. New equipment to detect these contaminants developed by VU researchers has been sold to other research groups all over the world. Now the researchers are taking the next step, together with IXA, to expand sales to water companies worldwide as well as other applications such as food and drug discovery research.
News